The table below shows Citius Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
-
-
$90.00K
$90.00K
$90.00K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$9.16M
$11.91M
$14.82M
$17.66M
$12.24M
$8.81M
SG&A
$18.53M
CTXR annual revenue (10-K history)
Citius Pharmaceuticals, Inc. reported annual revenue of $90.00K for fiscal year 2022. That is up 0.0% from $90.00K in fiscal 2021. Figures come from the company's audited annual reports as filed with the SEC.